论文部分内容阅读
为探讨重型病毒性肝炎（重肝）患者血清sICAM－1水平与病情的关系，应用酶联免疫法检测了7例正常人和29例重肝患者血清sICAM－1水平，并动态观察了7例患者不同时期的血清sICAM－1。重肝患者血清sICAM－1水平为1176．9±230．8ng／ml，与正常人（217．86±30．3ng／ml）相比升高
In order to explore the relationship between serum sICAM-1 and severity of disease in patients with severe viral hepatitis (severe liver), serum sICAM-1 level was measured by enzyme-linked immunosorbent assay in 7 normal subjects and 29 patients with severe hepatitis. Seven patients Patients with different periods of serum sICAM-1. Serum levels of sICAM-1 in patients with severe hepatitis were 1176.9 ± 230.8 ng / ml, which were significantly higher than those in normal subjects (217.86 ± 30.3 ng / ml)